Evidence map›Paper›PMID 40768188›Full record

ReviewAdvances in therapy2025

The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β

Luis Nannini, Zaurbek Aisanov, Kurtuluş Aksu, Ashraf Alzaabi, Miguel Antúnez, Leonora Cañizares-Fernandez, Mark Cohen-Todd, Michael G Crooks, Hisham Farouk, Suyapa Sosa Ferrari and 10 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Luis NanniniPulmonary Section, Hospital E Perón, Universidad Nacional Rosario, Granadero Baigorria, Argentina. neumo_heep@santafe.gov.ar.ORCID http://orcid.org/0000-0002-9868-9883
Zaurbek AisanovPulmonology Department, Pirogov Russian National Research Medical University, Moscow, Russia.
Kurtuluş AksuDivision of Immunology and Allergy, Department of Chest Diseases, University of Health Sciences Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, Turkey.
Ashraf AlzaabiPulmonology Department, Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Miguel AntúnezServicio Enfermedades Respiratorias. Servicio de Medicina Interna. Clínica Alemana, Santiago, Chile.
Leonora Cañizares-FernandezDivision of Pulmonary Medicine, Department of Medicine, College of Medicine & Philippine General Hospital, University of the Philippines-Manila, Manila, Philippines.
Mark Cohen-ToddHospital Centro Medico, Guatemala City, Guatemala.
Michael G CrooksHull York Medical School, Daisy Building, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK.
Hisham FaroukInternational Medical, AstraZeneca, Dubai, United Arab Emirates.
Suyapa Sosa FerrariServicio de Neumologia, Instituto Nacional Cardio Pulmonar, Tegucigalpa, Honduras.
Pin-Kuei FuDivision of Clinical Research, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Natalia GarciaSociedad Dominicana de Neumología y Cirugía de Tórax, Santiago, Dominican Republic.
Ashraf HatemDepartment of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt.
Truong Le Van NgocMinistry of Health and Long-Term Care, Hanoi, Vietnam.
Kittipong ManeechotesuwanDivision of Respiratory Disease and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Prannok Road, Bangkok, Thailand.
Walter Javier MattaruccoNeumonólogo, CEPROSS (Centro Profesional San Salvador), Entre Rios, Argentina.
John MpeSefako-Makgatho Health Sciences University, Dr George Mukhari Academic Hospital, Ga-Rankuwa, South Africa.
Francesc Xavier Moranta RibasFarmacia Moranta, Inca, Mallorca, Spain.
Jesús Javier Vázquez-CortésHospital Ángeles Lomas, Huixquilucan, Estado de Mexico, Mexico.
Faisal YunusDepartment of Pulmonology and Respiratory Medicine, Universitas Indonesia Faculty of Medicine, Persahabatan Hospital, Jakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma poses a significant global health problem. Despite the availability of effective treatments, management practices often fall short of current recommendations. The SABA use IN Asthma (SABINA) programme demonstrated that short-acting β

Indexed as

Adrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaFeasibility StudiesHumansPractice Guidelines as TopicQuality ImprovementAdrenergic beta-2 Receptor AgonistsAnti-Asthmatic AgentsAsthmaLow-and-middle-income countriesOver-reliancePay-for-performance programmesSENTINELShort-acting β2-agonists

Identifiers

PMID40768188
PMCPMC12474610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.